Loading…

Medtronic will buy Israeli medical device developer Visionsense for $75 million, including $40-50 million cash and $25 million in milestone payments. Visionsense develops minimally invasive surgical devices for brain surgery.
“US medical equipment company Medtronic will buy Israeli minimally invasive surgery technology developer Visionsense for $75 million, sources inform 'Globes.'”en.globes.co.il
Summarized from public sources; check the original articles before acting on it.